Multicenter Prospective Assessment of Coronary Microvascular Dysfunction: Primary Results of the FlowLab Study
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Abbott; Amgen; AstraZenca; Pfizer; Ionis; Inari Medical
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Abiomed; Terumo Medical Corporation; Bain Life Sciences, Endovascular Engineering, SpectraWAVE; Magenta Medical